Variant report
Variant | esv2760822 |
---|---|
Chromosome Location | chr4:21450944-21467397 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 1)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPR125-6 | chr4:21454062-21463909 | ucscGeneNc_uc003gqj_1 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-7978 | chr4:21466361-21466381 | MIMAT0031181 |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73249587 | chr4:21451030-21451031 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs79769507 | chr4:21451076-21451077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115505939 | chr4:21451091-21451092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146543890 | chr4:21451106-21451107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549221715 | chr4:21451109-21451110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12643143 | chr4:21451114-21451115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs528387437 | chr4:21451117-21451118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546916000 | chr4:21451188-21451189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192851000 | chr4:21451199-21451200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539853545 | chr4:21451205-21451206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200001446 | chr4:21451259-21451260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372881464 | chr4:21451260-21451261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs28405605 | chr4:21451261-21451262 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs34289367 | chr4:21451312-21451313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537098292 | chr4:21451317-21451318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73249588 | chr4:21451375-21451376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs28669010 | chr4:21451377-21451378 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs183585980 | chr4:21451387-21451388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371073682 | chr4:21451424-21451425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553655831 | chr4:21451425-21451426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562874230 | chr4:21451426-21451427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs578177075 | chr4:21451508-21451509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114526126 | chr4:21451589-21451590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563246956 | chr4:21451599-21451600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35784336 | chr4:21451622-21451623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575415065 | chr4:21451623-21451624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187493718 | chr4:21451669-21451670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192467694 | chr4:21451716-21451717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560427403 | chr4:21451728-21451729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528337161 | chr4:21451743-21451744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184708499 | chr4:21451783-21451784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565198342 | chr4:21451794-21451795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532276855 | chr4:21451811-21451812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62295494 | chr4:21451926-21451927 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs111295766 | chr4:21451940-21451941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569672740 | chr4:21451943-21451944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2199287 | chr4:21451964-21451965 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs549113669 | chr4:21451979-21451980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114131864 | chr4:21452059-21452060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535257018 | chr4:21452072-21452073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111602033 | chr4:21452080-21452081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578213828 | chr4:21452101-21452102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187977808 | chr4:21452175-21452176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1476279 | chr4:21452250-21452251 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs575353256 | chr4:21452263-21452264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372729960 | chr4:21452383-21452384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116983715 | chr4:21452415-21452416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192742592 | chr4:21452430-21452431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572814923 | chr4:21452432-21452433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs16871085 | chr4:21452437-21452438 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22737080 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21448400-21465600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:21449800-21454000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr4:21450800-21455200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:21451600-21455200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:21452200-21453600 | Enhancers | NH-A | brain |
6 | chr4:21452200-21455200 | Enhancers | HMEC | breast |
7 | chr4:21452200-21456200 | Enhancers | NHEK | skin |
8 | chr4:21452400-21453400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr4:21452400-21456200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr4:21452600-21453000 | Enhancers | HSMMtube | muscle |
11 | chr4:21452600-21453400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr4:21453400-21455800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr4:21454000-21455800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr4:21455200-21455400 | Bivalent Enhancer | HMEC | breast |
15 | chr4:21455200-21455600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr4:21455800-21456000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr4:21456600-21456800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |